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1. Introduction
A tumor is defined, in brief, as abnormal growth of tissue; tumoral formations are classified
under two main headings, benign and malignant. The oro-facial region including the jaw
bones, maxilla and mandible, is a site for a multitude of neoplastic conditions. Odontogenic
tumors (OTs) constitute a wide range and diverse kind of lesions derived from tooth forming
apparatus and its remnants. OTs originate from epithelium or ectomesenchyme or from both,
showing varying degrees of inductive interaction between these embryonic components of the
developing tooth germ. [1]. The majority of these tumors occur intraosseously within the
maxillofacial skeleton, while extraosseous odontogenic tumors occur nearly always in the
tooth-bearing mucosa. Due to their specific structure and location they have been identified
and classified by pathologists into a separate group, differing in histogenesis, biology, clinical
findings and radiological signs from other tumors developing in the oral cavity and facial
bones (Figure 1).
The aim of the chapter is to review multidisciplinary treatment approaches to pediatric patients
with benign jaw tumors from a radiological and clinical point of view and assess advantages
and disadvantages of the current treatment techniques, possible complications and their
prevention in the light of the recent literature.
1.1. Etiology of odontogenic tumors
According to current literatures, it is known that the potential sources for development of an
odontogenic tumor are varied, and these include:
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1. The pre-functional dental lamina (odontogenic epithelium with ability to produce a
tooth), which is more abundant distal to the lower third molars.
2. The post-functional dental lamina, a concept that covers those epithelial remnants such
as Serre´s epithelial rests, located within the fibrous gingival tissue; the epithelial cell rests
of Malassez in the periodontal ligament and the reduced enamel organ epithelium, which
covers the enamel surface until tooth eruption.
3. The basal cell layer of the gingival epithelium, which originally gave rise to the dental
lamina.
4. The dental papilla, origin of the dental pulp, which has the potential to be induced to
produce odontoblasts and synthesize dentin and/or dentinoid material.
5. The dental follicle.
6. The periodontal ligament, which has the potential to induce the production of fibrous
and cemento-osseous mineralized material [2].
Figure 1. Odontogenic tumors arising from odontogenic tissues
From a biological point of view, some of these lesions represent hamartomas with varying
degrees of differentiation, while the rest are benign or malignant neoplasms with variable
aggressiveness and potential to develop metastases. These tumors constitute a heterogeneous
group of diseases with diverse clinical and histopathological features [3]. The relative fre‐
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quency of OTs obtained from studies from different parts of the world, have varied widely.
Some authors have reported that OTs are rare with a relative frequency of 1%, while others
have reported OTs constitute up to 32% of jaw lesions [4-6]. These disparities have been
suggested to be due to the differences in terminology and classification and also, possibly due
to racial and or genetic differences in the occurrence of the various types of OTs. OTs comprise
a large heterogeneous group of lesions originating from the epithelium and/or odontogenic
ectomesenchyme and remnants. OTs include entities of a hamartomatous nature, such as
odontoma, benign neoplasms, some of which are aggressive as is the case of ameloblastoma
and myxoma and malignant neoplasms capable of metastasis [2, 7].
Primary jaw tumors are broadly classified into odontogenic and nonodontogenic groups. The
World Health Organization (WHO) classified this group of lesions in 1971 and 1992. In 2005,
the WHO published the latest updated edition of the classification of OTs. There were 6 major
changes in this schema from the previous versions namely:
1. parakeratinized variant of odontogenic keratocyst is now classified as a benign tumor and
termed KCOT
2. adenomatoid odontogenic tumor (AOT) originates from the odontogenic epithelium with
mature fibrous stroma and without ectomesenchyme
3. calcifying odontogenic cyst (COC) is divided into 2 benign and 1 malignant groups
4. clear cell odontogenic tumor is a malignant lesion and termed clear cell odontogenic
carcinoma (CCOC)
5. odontogenic carcinosarcoma is not included due to the lack of evidence for the existence
of this type and
6. some changes were made regarding terminology and subtypings [5-7].
The latest WHO classification has been used as a global standard for the last 10 years but our
knowledge of odontogenic tumors continues to evolve.
The latest WHO classification of odontogenic tumors
1. Malignant odontogenic tumors
Odontogenic carcinomas
Metastasizing (malignant) ameloblastoma
Ameloblastic carcinoma - primary type
Ameloblastic carcinoma - secondary type (dedifferentiated), intraosseous
Ameloblastic carcinoma - secondary type (dedifferentiated), peripheral
Primary intraosseous squamous cell carcinoma solid type
Primary intraosseous squamous cell carcinoma derived from keratocystic odontogenic tumor
Primary intraosseous squamous cell carcinoma derived from odontogenic cysts
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Clear cell odontogenic carcinoma
Ghost cell odontogenic carcinoma
Odontogenic sarcomas
Ameloblastoma fibrosarcoma
Ameloblastic fibrodentino-and fibro-odontosarcoma
2. Benign odontogenic tumors
Odontogenic epithelium with mature, fibrous stroma without odontogenic ectomesenchyme
Ameloblastoma, solid/multicystic type
Ameloblastoma, extraosseous/peripheral type
Ameloblastoma, desmoplastic type
Ameloblastoma, unicystic type
Squamous odontogenic tumor
Calcifying epithelial odontogenic tumor
Adenomatoid odontogenic tumor and Keratocystic odontogenic tumor
Odontogenic epithelium with odontogenic ectomesenchyme, with or without hard tissue
formation
Ameloblastic fibroma
Ameloblastic fibrodentinoma
Ameloblastic fibro-odontoma
Odontoma
- Odontoma, complex type
- Odontoma, compound type
Odontoameloblastoma
Calcifying cystic odontogenic tumor
Dentinogenic ghost cell tumor
Mesenchyme and/or odontogenic ectomesenchyme with or without odontogenic epithelium
Odontogenic fibroma
Odontogenic myxoma and myxofibroma
Cementoblastoma
Bone-related (Fibro-osseous) lesions
Ossifying fibroma
Fibrous dysplasia
Osseous dysplasia
Periapical Osseous Dysplasia
Focal Osseous Dysplasia
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Florid Osseous Dysplasia
Central giant cell granuloma
Cherubism
Aneurysmal bone cyst
Solitary (Simple) bone cyst
Other tumors
Melanotic neuroectodermal tumor of infancy
Classification of the Latest Benign Fibro-Osseous Lesions of the Craniofacial Complex: [8]
1. Bone dysplasias
a. Fibrous dyspla
i. Monostotic
ii. Polyostotic
iii. Polyostotic with endocrinopathy (McCune-Albright)
iv Osteofibrous dysplasia
b. Osteitis deformans
c. Pagetoid heritable bone dysplasias of childhood
d. Segmental odontomaxillary dysplasia
2. Cemento-osseous dysplasia
a. Focal cemento-osseous dysplasia
b. Florid cemento-osseous dysplasia
3. Inflammatory/reactive processes
a. Focal sclerosing osteomyelitis
b. Diffuse sclerosing osteomyelitis
c. Proliferative periostitis
4. Metabolic Disease: hyperparathyroidism
5. Neoplastic lesions (Ossifying fibromas)
a. Ossifying fibroma
b. Hyperparathyroidism jaw lesion syndrome
c. Juvenile ossifying fibroma
i. Trabecular type
ii. Psammomatoid type
d. Gigantiform cementomas
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In pace with new findings of new genetic and molecular changes, classification of odontogen‐
ic tumors will necessitate further modification and subsequent changes in the classification
system. Hence a new and revised version of the classification will always be dynamic. Charac‐
teristics and epidemiology of jaw tumors have been described mostly in adults. Compared with
their adult counterparts, jaw tumors in childhood show considerable differences. Tumors of
the head and neck represent only 2% to 5% of all pediatric tumors. OTs in children constitute
approximately 3% of all tumor like growths in the oral cavity, jaws and salivary glands in all
age groups [9]. In general, OTs in the pediatric population are rare and considerably more so
than in the adult population. There are differences in the spectrum of diseases seen in this group
and in adults. When the diseases are similar, there are sometimes differences in their clinical
behavior. There are additional management concerns when working with children. Treat‐
ment burden is given relatively greater consideration in children since they are growing and
developing and treatment may exert untoward influences therein. It is important for the
clinicians involved in the diagnosis and treatment of pediatric head and neck tumors to
understand certain patterns that follow the development of these lesions, so that misdiagno‐
sis and delays in treatment can be avoided. Because of their relative rarity, this broad spec‐
trum of lesions require careful attention and close collaboration between pediatricians, medical
oncologists, radiotherapists, pathologists and surgeons working in the head and neck area.
Pathology is uncommon among the pediatric age group, its incidence and prevalence has been
increasing in recent years, and it remains a significant cause of morbidity and mortality in this
population. Recently, Jones and Franklin performed a retrospective investigation of oral and
maxillofacial pathologies within a 30-year period. Those authors verified that biopsies in
patients aged between 10 and 16 years represented 8.2% of all cases reported.[10]
Classification of pediatric jaw tumors
The various classifications systems proposed by authors are enumerated as below:
1. Jaw Tumors in Children (11)
1.Classification of non-odontogenic jaw tumors in children
I. Benign mesenchymal tumors
a) Giant cell lesions
b) Fibro-osseous lesions
c) Myxoma
II. Hematopoietic and reticuloendothelial tumors
a) Langerhans cell histiocytosis
b) Burkitt’s lymphoma
c)Lymphoma
III. Neurogenic tumors
a) Neurofibroma
b) Neurilemmoma
c) Neuroma
d)Ganglioneuroma
e) Neuroblastoma
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f)Melanotic neuroectodermal tumor
IV. Vascular lesions
a)Vascular malformation (capillary, lymphatic, venous, arterial, combined)
b)Hemangioma
c)Aneurysmal bone cyst
V. Malignant mesenchymal tumors
a) Osteogenic sarcoma
b) Chondrosarcoma
c) Fibrosarcoma
d) Ewing’s sarcoma
VI. Malignant epithelial tumors
a)Squamous cell carcinoma
b)Mucoepidermoid carcinoma
c)Adenoid cystic carcinoma
d)Adenocarcinoma
2. Classification of odontogenic jaw tumors in children
I. Epithelial tumors
a) Ameloblastoma (Peripheral, Unicystic, Solid, Multicystic)
b) Adenomatoid odontogenic tumor
c) Calcifying epithelial odontogenic tumor
II. Mesodermal tumors
a)Cementoma
b)Periapical cemental dysplasia
c)Cementifying fibroma
d)Cementoblastoma
e)Odontogenic fibroma
III. Mixed tumors
a)Ameloblastic fibroma
b) Odontoma
3. Classification of Small Round Cell Tumors in children
1. Soft tissue Rhabdomyosarcoma
Soft tissue (extraosseous) Ewing’s sarcoma
Hemangiopericytoma
2. Osseous Ewing’s sarcoma
Small cell osteosarcoma
Mesenchymal chondrosarcoma
Hemangiopericytoma of bone
3. Neural
Neuroblastoma
Peripheral neuroectodermal tumors
- Askin’s tumor
- Neuroepithelioma
Pheochromocytoma
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4. International classification of childhood cancer (12)
Malignant Bone tumors
a) Osteosarcomas
b) Chondrosarcomas
c) Ewing tumor and related sarcomas of bone
d) Other specified malignant bone tumors
e) Unspecified malignant bone tumors
Soft tissue and other extraosseous sarcomas
a) Rhabdomyosarcomas
b) Fibrosarcomas, peripheral nerve sheath tumors and other fibrous neoplasms
c) Kaposi’s sarcoma
d) Other specified soft tissue sarcomas
e) Unspecified soft tissue sarcomas
2. Clinical sign and symptoms of pediatric jaw tumors
Pediatric patients encompass a very interesting study group, as several long term physiological
changes take place in the maxillofacial area. During the mixed dentition period, children can
refer with a complaint of swelling in the maxillofacial area, which may or may not be associated
with pain. These mostly include both hard and soft tissue pathologies. When involving bone,
only odontogenic cysts or odontogenic tumors as a category have been considered. Intra-
osseous pediatric jaw lesions can present in diverse clinical patterns and their diagnoses can
vary from odontogenic to non-odontogenic pathogeneses, which can rarely include connective
tissue pathology. The great majority of pediatric jaw tumors are non-odontogenic [13,14].
OTs can be observed casually or after the appearance of nonspecific symptoms. Because of
their slow-growth tendency, usually they do not cause pain. The odontogenic tumors grow in
the jaw, through the haversian system, without metastases but with a high probability of
relapse. In the majority of cases, tumors of the head and neck in children are first seen by
general practitioners or pediatricians with subsequent delays in investigations and diagnosis.
Some of these tumors may disappear spontaneously without any treatment. During the mixed
dentition period, children can report with complaint of swelling in the maxillofacial area,
which may or may not be associated with pain. A history of trauma also needs to be elicited,
because they are prone to falling down during playing, which can affect the jaws. Because of
the complex anatomy and development of the head and neck, neoplasms during infancy and
childhood arising at this site represent the most difficult challenges in clinical practice. [15]
3. Diagnosis of pediatric jaw tumors
The odontogenic cysts and tumors are a diverse group of lesions that represent deviation from
normal odontogenesis. The physical signs and symptoms of odontogenic cysts and tumors
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will depend to a certain extent on the dimensions of the lesion. A small lesion is unlikely to be
diagnosed on a routine examination of the mouth because signs will not be demonstrable. Such
lesions are only likely to be detected at an early stage as the result of routine radiographic
examination. Exceptions are some early lesions that may present in conjunction with a
devitalized tooth, which is detectable on clinical examination. Some cystic lesions may become
secondarily infected, leading to their diagnosis. Clinical absence of one or more teeth without
the history of extraction may also be a clinical indicator of an undiagnosed odontogenic cyst
or tumor because many of these lesions are associated with impacted or congenitally missing
teeth. As the lesion grows, other indirect changes may occur. An enlarging lesion between two
teeth can cause the crowns to converge and the roots to diverge. Growth that is nearly
undetectable visually may lead to difficulty with denture retention. As the lesion enlarges even
further, expansion of the bone may be seen directly. This is usually toward the buccal surface
of the alveolar bone because this is the thinnest area and expansion occurs here most easily.
Clinically evident expansion is often a late finding, especially in lesions developing within the
ramus or angle of the mandible or within the maxillary sinus. Lesions in these areas may
become extremely large before expansion is observed clinically. Masses in the neck confront
the pediatrician with greater opportunities for evaluation before a decision regarding biopsy
or excision is reached. Signs of systemic involvement must also be determined.
3.1. Radiographic and imaging studies
• The primary goals of radiographic assessment are to more precisely define the primary
lesion and to detect metastatic disease for clinical staging
• Chest radiographs are useful screens for mediastinal lymphadenopathy
• Ultrasound is able to differentiate a solid from a cystic mass, and give general relationships
of the mass to adjacent structures
• Axial and coronal computerized tomography (CT) allows documentation of bone erosion
and invasion of adjacent structures
• Magnetic resonance imaging (MRI) offers improved tissue contrast and definition
• Angiography delineates the blood supply to a lesion, and offers the ability to embolize
specific factors to decrease blood loss associated with excision of vascular lesions
• Bone scans and liver spleen scans offer modalities to detect systemic disease. [9, 16]
A tissue diagnosis becomes necessary in order to diagnose and initiate proper therapy.
3.2. Biopsy
• Biopsy of OTs allows histologic evaluation of the mass
• Excisional biopsy is often therapeutic as well as diagnostic
• Incisional biopsy is required in cases where the lesion is large, or the lesion is relatively
inaccessible
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• Fine needle aspiration for cytologic study is useful in salivary gland and thyroid gland
lesions. However, its generalized use for all pediatric head and neck masses is limited due
to the rarity of squamous or glandular neoplasms developing in children
• Large bore needle biopsy has no established role in the evaluation of head and neck
malignancies in children and has been reported to cause seeding along the needle tract in
children. [9, 16]
OTs have a specific histological structure reflecting various stages of odontogenesis and are
located mainly in the jaws, rarely in other parts of the skeletal system. Due to their specific
structure and location they have been identified and classified by pathologists into a separate
group of neoplasms differing from other lesions developing in the oral cavity and facial bones
[17]. Odontogenic tissue is programmed to produce dentin and enamel due to active interac‐
tions between odontogenic mesenchyme and epithelium. Tooth formation is achieved via
odontogenic mesenchyme and epithelium stage- and spatial-specific differentiation from early
tooth development to late maturation [18]. Therefore, when odontogenic tissue becomes
undifferentiated and undergoes tumoral changes, it has the potential to produce abnormal
calcifications with enameloid, dentinoid, and cementum-like material histologic features. For
this reason, these odontogenic calcifications are important odontogenic tumor characteristics
and occasionally are accompanied by odontogenic epithelium ghost cell change and amor‐
phous odontogenic mesenchyme hyalinization [19].
Aspiration cytology, a well established diagnostic tool in adult oncology, is recently gaining
acceptance in pediatric population, as clinicians add this technique to their diagnostic arma‐
mentarium. Fine-needle aspiration cytology is a useful and reliable tool in the diagnosis of
head and neck OTs with no contraindications and minimal complications even in children [20].
More than 95% of all OT reported in large series are benign and around 75% are represented
by odontomas, ameloblastomas and myxomas (which could be considered as “relatively
frequent OT”). Due to the inclusion of the odontogenic keratocyst as a tumor, these figures
will be modified significantly, as this lesion is more frequently diagnosed than the other three
entities. Some studies have shown epidemiological data that demonstrate that there is a second
group of OT, which, although rare in terms of general pathology, are of “intermediate
frequency” with respect to other OT, which have to be considered in the differential diagnosis
of tumors of the oral and maxillofacial regions; therefore they have to be included within the
contents of pathology of the graduate and post-graduate courses of oral and general pathology.
The lack of specific markers to confirm the odontogenic origin of all the lesions included in the
current WHO classification makes diagnoses mainly on anatomic considerations, or on the
histomorphological similarities among some tumors with the above mentioned odontogenic
structures. However, as most OT contain variable amounts of epithelium, and the fact that
such tissue may express several of the more than 20 cytokeratin markers (intermediate
filaments of the epithelial cells) known to date, there are some studies that have demonstrated
that cytokeratins 14 and 19 are the more frequently expressed by OT, and that these are also
expressed in the different epithelial structures of the developing tooth [21, 22], leading to
promote their use as a diagnostic tool to support the odontogenic nature of these entities.
Additionally, the expression of amelogenin, a representative protein of the enamel matrix,
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which is produced by secretory ameloblasts and that seem to actively participate in the process
of production and mineralization of enamel, has been consistently demonstrated within the
enamel matrix and the cytoplasm of the cells of the reduced enamel epithelium, stratum
intermedium and stellate reticulum of the enamel organ, as well as in some epithelial OT,
particularly at the basal endings of the cuboidal or columnar cells of ameloblastomas and in
cells of calcifying epithelial odontogenic tumor, malignant ameloblastoma and ameloblastic
carcinoma [22]. Therefore, the use of these markers is a valuable tool to discard other types of
epithelial lesions that may develop within the oral and maxillofacial regions. More recently,
calretinin, a 29-kDa calcium-binding protein has been shown to be expressed in both unicystic
and solid ameloblastomas but not in other types of odontogenic cysts, and this finding led
some authors to propose it may be considered a specific immunohistochemical marker for
neoplasitic ameloblastic epithelium [23] and an important diagnostic aid in the differential
diagnosis of cystic odontogenic lesions, particularly the keratocystic odontogenic tumor [24].
In the same way, the expression of cytodifferentiation of neoplastic epithelium via epithelial-
mesenchymal interactions and mineralization markers, such as bone morphogenetic protein
(BMP) is of great value to study those lesions that are characterized by the production of hard
dental tissues [25, 26].
4. Treatment of pediatric jaw tumors
The majority of tumors of the mouth and jaw in children are benign. Tanaka et al. reported
that only 3% of their cases were malignant in nature. In another study, benign tumors
composed 93% of the cases (13, 14, 27).
Treatment consists of a range of surgical methods, from surgical curettage to hemimandibu‐
lectomy and reconstruction with bone graft. Generally, surgical excision, curettage, cryosur‐
gery or en bloc resection are adequate for treatment of these tumors. However, some patients
need multiple treatment because of its specific criterias such as the clinical behavior and extent
of the lesion. Odontogenic lesions encompasses a wide spectrum of lesions and their variants,
which either can be a cyst or a tumor. Odontogenic cysts are derived from the epithelium
associated with the development of the dental apparatus while a tumor forms through some
aberration from the normal pattern of odontogenesis. But the fact, that these lesions can mimic
each other can complicate the diagnosis. The Adenomatoid Odontogenic Tumor is a benign,
nonaggressive odontogenic tumor which has been known by a number of descriptive names
since it was first reported. In almost all instances, the lesion may be removed by surgical
enucleation. Unicystic Ameloblastoma is another tumor of the odontogenic series which has
been described as benign but locally invasive. The Dentigerous Cyst, a cyst of odontogenic
origin, has the potential of transforming into an Ameloblastoma. The Odontogenic Keratocyst,
is characterized by aggressive behavior has debatable treatment options. All OTs can have a
similar clinical and radiographic features which can mislead the dentist and a biopsy is needed
to make a final diagnosis. Of all odontogenic tumors, ameloblastomas are the most controver‐
sial in terms of treatment. Treatments range from surgical curettage to bloc excision or resection
[28]. Surgical excision in the infant or child is sometimes met with resistance by both parents
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and physicians, yet with many tumors surgery is clearly the best treatment. A wide resection
for some tumors may pose psychological and cosmetic difficulties that parents can learn to
accept if these difficulties are discussed in an open and helpful manner. When parents accept
their children disabilities, the children in turn, can adjust very well functionally and psycho‐
logically following operations [29]. Cryosurgery is relatively new to the management of head
and neck tumors in children. Local freezing has the ability to destroy tumor cells. A wide
variety of probe tips are available to treat lesions of the skin, nose, mouth, nasopharynx,
oropharynx, hypopharynx and larynx. Unlike surgical excision or radiation therapy, cryosur‐
gery has the capability of destroying the tumor and only minimally affecting the surrounding
normal tissue; also unlike radiation therapy,cryosurgery can be repeatedly administered to a
specific area should the tumor persist or recur. The role of cryosurgery is still being assessed,
but the potential is both great and exciting [29]. In planning treatment for pediatric tumors,
authors stress the importance of the growth development of the jaw, and of esthetics and
functional concerns in later periods of life [30].
5. Benign odontogenic tumors
5.1. Odontogenic epithelium with mature, fibrous stroma without odontogenic
ectomesenchyme
5.1.1. Ameloblastomas have been classified as follows (WHO 2005 classification)
• Ameloblastoma, solid/multicystic type
• Ameloblastoma, extraosseous/peripheral type
• Ameloblastoma, desmoplastic type
• Ameloblastoma, unicystic type
Ameloblastoma is a tumor of the odontogenic epithelium, first described by Cusick in 1827.
Ameloblastoma is perhaps the most perplexing of all odontogenic neoplasms due to its
unexplainable clinical and histopathological behavior [31] It accounts for less than 1% of all
odontogenic cysts and tumors. Although all ameloblastomas have the same cell of origin, there
are several biologically distinct forms. The differences are especially important in pediatric
cases. Central ameloblastomas occur as unicystic, multicystic or solid lesions. Ameloblastoma
is non-encapsulated and infiltrates surrounding bone marrow. Even though they are locally
infiltrative, they can rarely metastasize. They may occur in any part of both jaws but most are
in the middle and posterior regions of the mandible. Ameloblastomas are always purely
radiolucent and may be unilocular but frequently become multilocular as they increase in size.
If not found and treated early, they will expand the jaws. Despite being categorized as benign
tumors, ameloblastomas have a high rate of recurrence, and there is a risk of malignant
transformation when treated inadequately. Clinically, ameloblastoma frequently manifests as
a painless swelling, which can be accompanied by facial deformity, malocclusion, and loss of
dentition, ulceration and periodontal disease. Sometimes pain occurs with varying intensities,
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but often quite low. It is not known whether the cause of the pain is pressure from the tumor
on peripheral nerves or secondary infection [32].
The unicystic ameloblastoma resembles a dentigerous or primordial cyst clinically and
radiographically and often occurs in teenage patients. Multicystic or solid ameloblastomas
occur most commonly in patients 30 to 50 years of age and are extremely rare in childhood.
Choung and Kaban in review of pediatric jaw tumors found only one case in 10 years. In the
pediatric population, ameloblastoma must be considered in the differential diagnosis of
radiolucent lesions of the jaws. In the vast majority of pediatric cases, however, these turn out
to be either odcontogenic or non-odontogenic cysts or non-odontogenic primary jaw tumors.
The two ameloblastic lesions that are found in childhood are the ameloblastic fibroma and the
unicystic ameloblastoma.The ameloblastic fibroma appears as an asymptomatic radiolucent
lesion, often associated with an impacted tooth and indistinguishable from an odontogenic
cyst. The patients are usually under 12 years of age. The unicystic ameloblastoma occurs in
teenagers, most commonly in the mandible. The patient exhibits a painless facial swelling or
radiolucency, usually associated with an impacted third molar. The lesion is most commonly
unilocular and may produce cortical expansion or perforation. Roots of adjacent teeth may be
displaced or resorbed. Aspiration reveals clear serous fluid from a cystic mass [33].
There has been some debate regarding the most appropriate method for surgical removal of
ameloblastomas. These range from conservative to radical modes of treatment. The conserva‐
tive modalities include curettage, enucleation and cryosurgery; while the radical modalities
are marginal, segmental and composite resections. The recommended treatment for amelo‐
blastoma in children should be radical resection, 0.5 to 1 cm past what appears to be normal
bone [34]. Treatment of both unicystic ameloblastomas and ameloblastic fibromas consists of
enucleation [33] Simple curettage is usually met with recurrence. It has been reported that
pediatric ameloblastomas are generally unicystic and do not extend beyond the cystic wall of
the tumor cell. [30] This type of tumor has a much better prognosis (Figure 2).
Early diagnosis is the most important component of therapy for this odontogenic tumor,
which  does  not  have  specific  radiographic  features  in  the  early  stages.  In  particular,
unilocular ameloblastoma may be difficult to diagnosis for the surgeon. Surgical enuclea‐
tion  with  bony  curettage  and  intra-operatory  cryostat  examination  of  the  lesion  allows
preservative treatment and reduction of the risk of relapse [35]. The loss of permanent teeth,
removed during the surgical  treatment,  will  require  orthodontic-prosthetic  rehabilitation
when the patient reaches adult age. Peripheral ameloblastoma occurs in soft tissue outside
and overlying the alveolar bone. This neoplasm arises from the basal layer of the surface
epithelium or remnants of the dental lamina. It occurs most frequently in the fourth to sixth
decade and has a slight male predilection. The mandible is affected twice as frequently as
the  maxilla.  Seldom  does  this  neoplasm  exhibit  any  radiographic  findings.  Superficial
erosion in the alveolar region is occasionally observed. The microscopic pattern of periph‐
eral  ameloblastoma  is  similar  to  that  of  central  ameloblastoma;  however,  it  lacks  the
invasiveness  of  its  central  counterpart.  Most  peripheral  ameloblastomas  are  acanthoma‐
tous. This lesion can be confused with peripheral odontogenic fibroma because features of
both lesions may be present. However, in the hands of an experienced oral pathologist the
Multidisciplinary Management of Benign Jaw Tumors in Children
http://dx.doi.org/10.5772/59341
285
 
(a) 
 
(b) 
 
(c) 
 
(d) 
 
Figure 2. (a): Ameloblastoma: Orthopantomograph of a 12-year-old boy who had a painless bony- hard swelling of the
left mandible associated with cortical expansion. (b): Radiological appearance after surgical treatment. (c): Radiological
appearance taken 24 months post-operatively. (d): Presurgery photographs showing the left mandible associated with
cortical expansion and postoperative clinical control at 12 and 24 months
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diagnosis  is  generally  not  difficult.  Because this  lesion is  relatively  innocuous,  noninva‐
sive, and displays little tendency for recurrence, it is treated by local excision. Despite its
behavior, 1-year follow-up examinations are recommended [36, 37].
5.1.2. Squamous odontogenic tumor
The squamous odontogenic tumor (SOT) is a rare and benign neoplasm frequently located
within the jaws. In 1975, Pullon et al. identified this entity and reported it for the first time in
a series of 6 cases. This benign tumor has a slow and gradual growth that might invade the
trabecular bone, destroying the cortical bone and infiltrating adjacent structures. Its aetiology
remains unknown although it could be originated from the epithelial remnants of the Malassez.
It usually appears over the lateral radicular surface of an erupted tooth and diminishes the
height of alveolar bone causing tooth mobility. There is a similar entity that is characterized
by squamous odontogenic tumor like proliferations (SOTLP) with a very similar histological
pattern than the SOT. This lesion commonly is located in the wall of an odontogenic cyst and
has a non-neoplastic character like in the SOT, representing probably, an hamartomatous
lesion. [38]
5.1.3. Calcifying epithelial odontogenic tumor
The calcifying epithelial odontogenic tumor (CEOT) is a rare tumor. It was first described as
a separate pathologic entity by a Dutch pathologist Jens Jorgen Pindborg in 1955. The term
“Pindborg’s tumor” was first used by Shafer and colleagues in 1963. CEOT is a rare benign
odontogenic epithelial neoplasm representing about 0.4-3% of all odontogenic tumors. This
tumor more frequently affects adults in the age range of 20-60 years, with a peak incidence in
the 5th decade of life with equal sex predisposition. CEOT is a rarely seen odontogenic tumor
in pediatric patients. It is a benign, but locally aggressive tumor; of all the odontogenic tumors,
CEOT accounts for 1% of the cases. Approximately 200 cases have been reported to date.
Although the tumor is clearly of odontogenic origin, its histogenesis is still uncertain. It usually
involves the premolar-molar area of the mandible with about 50% cases associated with
unerupted or embedded teeth. Etiology of this lesion is not clear. In the 113 cases reviewed by
Franklin and Pindborg, patients ranged from 8 to 92 years with a mean age of 40 years.
Radiographically, this tumor is often mistaken for a dentigerous cyst or ameloblastoma [39].
The diagnosis of CEOT is based on histological examination, revealing polyhedral neoplastic
cells which have abundant eosinophilic, finely granular cytoplasm with nuclear pleomorphism
and prominent nucleoli. Most of the cells are arranged in broad ramifying and anastomosing
sheet-like masses with little intervening stroma. An extracellular eosinophilic homogenous
material staining like amyloid is characteristic of this tumor with concentric calcified deposits,
resembling psammoma bodies called “Liesegang rings. A painless, slow-growing swelling is
the most common presenting sign. The differential diagnosis includes adenomatoid odonto‐
genic tumor, calcifying odontogenic cyst, dentigerous cyst, ameloblastic fibro-odontoma and
odontoma. It is an infiltrative neoplasm and causes destruction with local expansion. Definitive
resection of the entire mass with tumor-free surgical margins (en bloc resection) is the preferred
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treatment as tumor will recur if not completely removed. Long-term follow ups are recom‐
mended (Figure 3). Local recurrence rates of 10-15% have been reported [40]
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Figure 3. (a): Pindborg (CEOT) tumor associated with impacted premolar. Preoperative clinical (left) and radiological
appearance of CEOT (right). (b): Clinical appearance of CEOT and impacted premolar tooth. (c): Postoperative opera‐
tion site and macroscopic appearance of the mass. (d): Application of surgical obturator. (e): Postoperative clinical (left)
and radiological control (right) at 12 months.
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5.1.4. Adenomatoid Odontogenic Tumor (AOT)
This is a tumor mostly of teenagers. It occurs in the middle and anterior portions of the jaws
in contrast to ameloblastoma which is found mostly in the posterior segment. Two-thirds occur
in the maxilla and it is more common in females. The tumor may be partially cystic, and in
some cases solid lesion may be present as masses in the wall of a large cyst. It is believed that
lesion is not a neoplasm” Philipsen et al. subdivided this condition into three groups referred
to as follicular, extrafollicular, and peripheral. These variants have common histologic
characteristics that indicate a common origin as derived from the complex system of dental
lamina or its remnant [41].The follicular and extrafollicular variants account for 96% of all AOT
and of these 71% are follicular variants.The peripheral variant is the rarest with only 18 cases
reported so far [42]. The follicular variant is predominantly associated with the crown and
often part of the root of an impacted (unerupted) tooth (Figure 4). The most frequently
associated tooth is the maxillary canine rarely the permanent molars. Based on the clinical and
radiographic examination the follicular variant is often initially mistaken as dentigerous cyst.
This tumor is encapsulated and is treated by curettage with a recurrence rate approaching zero.
The radiographic appearance is a unilocular radiolucency, often around the crown of an
unerupted tooth in which case they resemble a dentigeous cyst.. A homogeneous, eosinophilic
and amorphous material may occasionally be found in AOT [43]. If they are present in
sufficient size and number, they may show on the radiograph as a “snow-flake” pattern
5.1.5. Keratocystic odontogenic tumor
The Keratocystic Odontogenic Tumor (KCOT) has been defined by the World Health Organ‐
ization In 2005, as a benign intraosseous neoplasm of odontogenic origin with characteristic
lining of parakeratinized squamous epithelium. It represents approximately 10 percent of all
jaw cysts and may occur in a wide age range of patients. About 70 percent or more cases involve
the mandible, especially in the molar, angle and ramus regions. The clinical features associated
with the keratocystic odontogenic tumor show it to be a unilocular or multilocular radiolu‐
cency. It is generally believed that these lesions originate from remnants of the dental lamina
in the same way as the primordial cyst. However, a tooth is generally not missing and,
therefore, they are believed to originate from additional remnants of the lamina not involved
in tooth formation. Alternatively, in some cases they may arise from the oral mucosa, partic‐
ularly in the retromolar region, because daughter cysts are found between the oral mucosa
and the cyst in the retromolar region [44].
Symptoms such as pain, swelling and drainage may be present, especially with larger lesions.
However, at least half of all lesions are discovered as incidental radiographic findings. Due to
the propensity of KCOTs to grow within the medullary bone, they have the potential to become
extremely large without causing any clinical signs or symptoms. Radiographically, the KCOT
presents as a well defined radiolucency with thin corticated margins. These tumors are
normally diagnosed histologically from a sample of the lining. With simple enucleation, it
seems that the recurrence rate may be from 25% to 60%. Approximately 20-40 percent of these
tumors are associated with an unerupted tooth and can be identical in appearance to a
dentigerous cyst (Figure 5). Root resorption is relatively uncommon. The classic treatment of
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this lesion is surgical marsupialization, enucleation and curettage being performed through
an intraoral approach. KCOTs have a high recurrence rate and develop more aggressively than
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 Figure 4. AOT associated with canine tooth. Oral photograph showing an anterior maxillary swelling in a 16-year-oldgirl. Preoperative radiological appearance of AOT. (b): Oral photograph showing large buccal anterior exspansion.
Clinical appearance of the mass being removed. (c): Clinical appearance of the encapsulated mass and the operation
site after enucleation. (d): Postoperative appearance of the operation site
A Textbook of Advanced Oral and Maxillofacial Surgery Volume 2290
any other jaw cyst. Based on the high rate of recurrence, most authors advocate radical
enucleation for small unilocular keratocysts and suggest resection and bone grafting for very
large lesions. But there is a general agreement that complete removal of large multilocular
KCOTs of the mandible ramus may be difficult because of the possibility that remnants of
cystic tissue or that satellite microcysts may be left behind. Most authors have shown the
successful treatment of large KCOTs using the technique of decompression and irrigation. The
benefits of this protocol over more conventional approaches (enucleation, en bloc resection)
lie in the minimal surgical morbidity. In addition, the associated structures such as the inferior
alveolar nerve and developing teeth are less vulnerable to damage. Morgan et al. reported that
treatment with Carnoy’s solution did not show a significant association with recurrence. Most
reports point out that recurrence will appear within the 5 to 7 years [45, 45].
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Figure 5. (a): KCOT. Frontal photograph and radiograph showing a 14-year-old boy presenting a posterior mandibular
radiolucency associated with impacted left third molar. (b): Oral and radiographic appearance of the operated area
with gauze tamponade after cystostomy and application of the surgical obturator.
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5.2. Odontogenic epithelium with odontogenic ectomesenchyme, with or without hard
tissue formation
5.2.1. Ameloblastic fibroma
This tumor, at least conceptually, is a compound odontoma and which includes the amelo‐
blastic fibradentinoma, ameloblastic odontoma and complex odontoma [46]. All show
evidence of inductive interaction between odontogenic epithelial and ectomesenchymal
components, but only the ameloblastic fibroma lacks hard tissue formation. The ameloblastic
fibroma presents as a jaw swelling and multilocular radiolucency in the lower premolar or
molar region or, less commonly, in the maxilla. This is a tumor of childhood, the typical patient
is about 12 –14 years old, seldom is it seen beyond age 20 yrs. The posterior segment of the
mandible is the most common location. Local swelling or failure of teeth to erupt on time or
in proper alignment may call attention to the tumor. Ameloblastic fibromas are purely
radiolucent. Small lesions may be unilocular but larger lesions are ordinarily multilocular.
Both odontogenic epithelium and odontogenic ectomesenchyme contribute to this tumor (an
odontogenic mixed tumor not to be confused with the mixed tumor of the salivary gland). The
epithelium grows in small islands and cords. This tumor is clearly benign and is ordinarily
treated by vigorous curettement. The recurrence rate is placed at about 15 %. Even though this
tumor is comprised of both odontogenic epithelium and odontogenic ectomesenchyme, it does
not secrete either enamel matrix or dentin. Its microscopic structure like its radiographic
appearance, is reminiscent of that of the ameloblastoma, but with two major differences: the
connective tissue component resembles dental papilla; and the stellate reticulum zone of the
epithelium is poorly developed. The ameloblastic fibroma poses two further problems: for the
histopathologist, it must be distinguished from a developing complex odontoma; and for the
surgeon, the requirement for complete excision must be weighed against the need to preserve
the developing jaw bones and dentition [40].
5.2.2. Ameloblastic fibrodentinoma and Ameloblastic fibro-odontoma
Ameloblastic fibrodentinoma (AFD) and ameloblastic fibroodontoma represent, at least for
didactic purposes, intermediate stages between the ameloblastic fibroma and the complex
odontoma. They also represent the interface between hamartomas and neoplasms, and occur
in late adolescence or in early adulthood. A classic site for the formation of an ameloblastic
fibrodentinoma is within, or adjacent to, the follicle of an unerupted tooth, typically a lower
third molar, in its path of eruption. Most often it presents as a symptomless radio-opacity and
may not be the cause of the failure of the underlying tooth to erupt (Figure 6). The ameloblastic
fibro-odontoma is a more variable entity and, as already noted, may be hard to distinguish,
clinically, radiographically and histopathologically, from a developing complex odontoma or
ameloblastic fibroma. The majority of ameloblastic fibro-odontomas are small, mixed radio-
opaque ⁄ radiolucent lesions that occur across a similar age-range to the ameloblastic fibro‐
dentinoma, and most are small and unilocular with limited growth potential after completion
of tooth formation. They show features that suggest the formation of tooth-like structures,
complete with tubular dentine and varying degrees of enamel matrix calcification. That this is
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not a developing odontoma is suggested by its perceived continued growth potential (hence
the belief that at least some are true neoplasms) and its presentation at an age when odontomes
have normally “matured” and become quiescent, as well as incorporating an extensive soft
tissue (radiolucent) component that somewhat resembles ameloblastic fibroma [40, 46]. A
regular follow-up protocol should be established to rule out any evidence of recurrence and
malignant transformation. A detailed study is required in order to understand the relationship
of AFD and related lesions, their biological behavior and management strategies [47].
Figure 6. Ameloblastic fibro-odontoma. This combines the radio-opaque component that resembles a complex odonto‐
ma with radiolucent soft tissue that histologically combines the features of ameloblastic fibroma with the early stages
of tooth germ development.
5.2.3. Odontoma
• Odontoma, complex type
• Odontoma, compound type
Odontomas are hamartomas of aberrant tooth formation, which occur due to budding of extra-
odontogenic epithelial cells or detachment of odontogenic cells from the dental lamina [48].
These odontogenic cells may in turn differentiate and deposit enamel, dentine, cementum or
pulp in the form of multiple teeth like structures (compound odontoma), amorphous calcified
masses (complex odontoma) or a combination of both (composite odontoma and compound‐
complex odontoma). Trauma to the tooth bud during its early developmental stages has been
proposed as a possible predisposing factor for the origin of odontoma. [49,50].
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As a result, these tumors are mostly radiodense. In the compound odontoma, multiple small
and malformed tooth-like structures are formed creating a “bag of marbles” radiographic
appearance. In the complex odontoma, there is little or no tendency to form tooth-like
structures. The dentin and enamel are entwined in a mass that bears no resemblance to teeth.
Both types of odontoma are found in the early years, usually in the teens or early twenties.
Compound odontoma is more common in the anterior jaw segment whereas the complex type
is found more commonly in the posterior jaws (Figure 7). Many are associated with an
unerupted tooth. Odontomas behave more like developmental abnormalities (hamartomas)
than true neoplasms. Although they may reach a large size, they do eventually cease growing
in contrast to true neoplasms which show continuous growth. Treatment is elective surgery.
They have a limited growth potential and cause no pain or cosmetic deformity [46].
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NOTE: We have skipped odontoameloblastoma, calcifying cystic odontogenic tumor, denti‐
nogenic ghost cell tumor, malignant ameloblastoma,ameloblastic carcinoma, clear cell
odontogenic carcinoma because they are exceedingly rare.
Figure 7. a): Compound odontoma associated with two mesiodens. Photograph and radiograph showing a 11-year-old
boy presenting an anterior maxillary radiolucency with impacted supernumerary teeth and radio-opaque mass. (b):
Macroscopic appearance of the supernumerary teeth and postoperative operation site
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5.3. Mesenchyme and/or odontogenic ectomesenchyme with or without odontogenic
epithelium
5.3.1. Odontogenic fibroma
Central odontogenic fibromas are encountered as unilocular radiolucencies that turn out to be
solid, rather than cystic, following enucleation. They are rare, far rarer for example than
ameloblastomas, and arise usually anterior to the molars, more commonly in the maxilla and
mainly in women, as a small, well-circumscribed radiolucency that may cause resorption and ⁄
or displacement of adjacent vital teeth (Figure 8). A wide age-range is noted among the
relatively few reported cases, and a scalloped radiographic margin may denote a more
aggressive behavior pattern. Following enucleation, most odontogenic fibromas do not recur,
although there have been occasional reports of some following a more aggressive course;
however, there seems to be little correlation with the histological pattern [40, 46]
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Figure 8. (a): Odontogenic fibroma. Radiograph showing a 12-year-old boy presenting with a posterior mandibular
mass associated with an impacted left first molar tooth. (b): Orthodontic extrusion of the impacted first molar using the
zygomatic bone anchor and clinical appearance after the right first molar extrusion
5.3.2. Odontogenic myxoma/myxofibroma
Despite the name similarity, the odontogenic myxoma is quite a different entity from the
odontogenic fibroma in almost all respects. Odontogenic myxoma (OM) of the jaws, first
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described by Thoma and Goldman in 1947, is believed to arise from odontogenic ectomesen‐
chyme [51, 52]. It is a rare benign tumor characterized grossly by mucoid or gelatinous grayish-
white tissue that replaces the cancellous bone and expands the cortex. OMs are locally invasive,
non-metastasizing neoplasms of the jaws, almost exclusively seen in tooth-bearing areas. It
accounts for 0.2-17.7% of odontogenic tumors. It predominantly involves the mandible and
maxillary tumors are known to be more aggressive than tumors involving the mandible [53].
Most frequently, OMs occur in the 2 nd and 3 rd decades of life. Cortical expansion and
perforation are common findings; however, maxillary myxomas often extend into the sinus
[54]. Radiographically, the tumor presents as a unilocular or multilocular radiolucent lesion
with fine, bony trabeculae within its interior structure expressing a honeycombed, soap bubble,
or tennis racket appearance [55]. A histologic characteristic of this tumor resembles the
mesenchymal portion of a tooth in development. The lesion is not encapsulated being
characterized by the proliferation of a few rounded cells, fusiforms and star cells, being
included in abundant myxomatous stroma with a few collagen fibers [56]. They are uncom‐
mon. Extragnathic skeletal lesions are a rarity. Since it does not produce a calcified matrix
material, it is purely radiolucent. If allowed to reach a large size, it takes a big operation to
remove it [40].
5.3.3. Cementoblastoma
Cementoblastoma in the current World Health Organization classification of odontogenic
tumors, is in the category of tumors of mesenchyme and/or odontogenic ectomesenchyme with
or without odontogenic epithelium [57]. The lesion was first recognized by Noeberg in 1930
[58]. The lesion is considered as the only true neoplasm of cementum origin. It generally occurs
in young persons, comprises <1-6.2% of all odontogenic tumors and is characterized as being
attached to the roots, most frequently associated with first permanent molars [59]. The
differential diagnosis for a periapical radiopacity include cementoma, osteoblastoma, periap‐
ical cemental dysplasia, condensing osteitis and hypercementosis. The majority of these
tumors are radiopaque, but a radiolucent tumor may occur in rare instances. Histologically, it
presents as a well-circumscribed tumor composed of cementum like tissue surrounded by a
fibrous capsule. Surgical enucleation of the cementoblastoma with the associated tooth is
usually curative, although recurrences have been reported following incomplete excision. The
recurrence rate is 21.7-37.1% [60, 61].
5.4. Bone-related (Fibro-osseous) lesions
5.4.1. Juvenile ossifying fibroma
Benign fibro-osseous lesions of the head and neck region are uncommon and constitute a
wide  range  of  tumors  sharing  some  histopathological  features.  This  group  includes
developmental, reactive or dysplastic lesions as well as neoplasm such as fibrous dyspla‐
sia  (FD),  ossifying  fibroma  (OF),  and  cemento-osseous  dysplasia  (COD)  [62].  Ossifying
fibromas are rare benign, neoplasms arising from undifferentiated cells of the periodontal
ligament  tissues  (63).  These  have  been  described  as  demarcated  or  rarely  encapsulated
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neoplasms consisting of fibrous tissue containing varying amounts of mineralized materi‐
al resembling bone and/or cementum which is one of its principal characteristics [64]. In
1872, Menzel first described ossifying fibroma, but in 1972, Montgomery assigned terminol‐
ogy to it. It accounts for 3.1% of all oral tumors and for 9.6% of all gingival lesions. There
are two types of ossifying fibroma, central and peripheral. The central type arises from the
endosteum  or  periodontal  ligament  adjacent  to  the  root  apex  and  expands  from  the
medullary cavity of the bone. The peripheral type occurs solely on the soft tissue overly‐
ing the alveolar process.  Trauma or local irritants are known to precipitate the develop‐
ment of this lesion [65]. It is common in young adults (especially, 2nd and 3rd decades)
with a female predominance and is generally asymptomatic until the growth produces a
noticeable swelling most often found in interdental gingiva, located anterior to molars and
in the maxilla [66].  The suggested etiology although unknown has been associated with
inflammatory  hyperplasia  of  the  periodontal  ligament  [67].  When  ossifying  fibroma  is
diagnosed in young people the term "juvenile" is used. The accurate nature and classifica‐
tion of JOF has undergone considerable debate among pathologists, resulting in a confus‐
ing  evolution  of  competing  nomenclatures  [68]  According  to  the  WHO classification  of
odontogenic  tumors 2005,  JOF is  further  subdivided into two distinct  clinic-pathological
variant  i.e.,  juvenile  psammornatoid  ossifying  fibroma  (JPOF)  and  juvenile  trabecular
ossifying fibroma (JTOF) [69]. Juvenile psammornatoid ossifying fibroma (JPOF) is a rare
fibro-osseous neoplasm that arises within the craniofacial  bones in individuals under 15
years of age, and these lesions are usually benign and tend to grow slowly. JPOF is rare
fibro-osseous neoplasm. Probability of malignancy makes this lesion worrysome. The lesion
is nonencapsulated but well demarcated from surrounding bone. JPOF mainly involves the
bones of the orbit and paranasal sinuses, whereas the trabecular type commonly involves
the  jaws.  JPOFs  are  rare,  benign,  potentially  aggressive  fibro-osseous  tumors  of  the
craniofacial bones characterized by the presence of numerous calcified spherules within an
actively  proliferating  connective  tissue  stroma.  They  are  mainly  seen  in  the  sino-naso-
orbital region of young individuals. Males and females are equally affected. The maxilla
and the mandible are the dominant sites of incidence. Occurrence in the maxilla is slightly
more  frequent  than in  the  mandible  (Figure  9)  The  incidence  of  JPOF is  still  unknown
because of relatively few cases reported till date. The pathogenesis of JPOF jaw lesions are
related  to  the  maldevelopment  of  basal  generative  mechanism that  is  essential  for  root
formation. The developing tooth can either be displaced, missing or remain unerupted. It
tends to occur at younger age group and is locally aggressive and these characteristics make
them  different  from  conventional  ossifying  fibroma  and  other  fibro-osseous  lesions.
Moreover, this lesion may clinically manifest with rapid painless expansion of the affect‐
ed bone as an aggressive lesion mimicking malignancy such as osteosarcoma. JPOF can be
easily  excluded  from  malignant  bone  tumors  on  the  routine  histological  examination.
Additionally, it may be difficult to distinguish JPOF from other fibro-osseous lesions because
of the overlapping features. It is important to accurately recognize JPOF for reaching the
diagnosis  and  treatment  planning.  Because  of  this  lesion's  aggressive  nature  and  high
recurrence rate, early detection and complete surgical excision are essential [40, 46].
Multidisciplinary Management of Benign Jaw Tumors in Children
http://dx.doi.org/10.5772/59341
297
 
(a) 
 
(b) 
 
(c) 
 
(d) 
Figure 9. (a): JPOF. Photograph showing a 14-year-old boy presenting an anterior maxillary expansion associated with
impacted left canine tooth ; Preoperative facial view showing asymmetry of face (left); Preoperative radiograph show‐
ing large radiolucency, well-defined sclerotic border around the upper left impacted canine tooth (right). (b): Clinical
and radiographical appearance of buccal cortical expansion. (c): Clinical appearance after enucleation and the mass.
(d): Postoperative panoramic radiograph showing normal bone pattern
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5.4.2. Central giant cell granuloma
There are a number of lesions that occur in the jaws that contain giant cells within them. They
include cherubism, giant cell granuloma of the jaws, giant cell tumor, aneurysmal bone cyst,
traumatic bone cyst and brown tumor of hyperparathyroidism. Their relationship to each
other, however, is ill defined. The histological similarities with the finding of multinucleated
giant cells of osteoclastic origin and the lesions themselves greatly differ in their genetic origin,
etiopathogenesis and clinical behaviour. Central giant cell granuloma (CGCG) is fairly
common in the jaws and it is a nonneoplastic bone disease, probably reactive to some unknown
stimulus. CGCG constitutes approximately 7% of the benign jaw tumors. Usually, it occurs in
patients 30 years of age or younger with painless swelling and an asymmetry in facial
appearance. The clinical behavior of CGCG ranges from a slowly growing asymptomatic lesion
to an aggressive lesion manifesting with pain, local bone destruction, root resorption, or
displacement of teeth. The highest rate of occurrence is the mandible, and most mandibular
lesions occur anterior to the first molars.
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Figure 10. (a). CGCG: Photograph showing a 13-year-old boy presenting a posterior mandibular lesion at premolar re‐
gion (a): Preoperative facial view showing ulcerative mass (left): Preoperative radiograph showing the lesion. (b): Ex‐
cised pathologic mass associated with tooth ; Postoperative panoramic radiograph showing normal bone pattern.
Clinical view taken 13 months post-operatively
Its etiology is still unknown and its biological behavior is poorly understood. This lesion occurs
almost exclusively within the jaw bones. It usually presents as a painless swelling of the
jawbone. Radiographically, CGCG presents as radiolucent defect, which may be unilocular or
multilocular. The defect usually is well-circumscribed and, in some cases, displacement of
teeth can be found (Figure 10). Conventional treatment for the CGCG has been local curettage
and this has been associated with a high success rate and low recurrence rate. The conservative
surgical treatment of CGCG usually involves curettage alone or along with peripheral
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ostectomy with no evidence of disease in a 2 year follow up perior. The margins of the CGCG
may also be thermally sterilized with a laser or a cryoprobes. Radical surgical techniques of
resection without continuity defect, peripheral ostectomy and en-bloc resection have some‐
times been justified for aggressive CGCG. Pediatric patients necessitate conservative manage‐
ment to prevent long term developmental defects. Steroids and calcitonin have been advocated
recently for inhibition of osteoclastic activity. Equal parts of triamcinolone acetonide (10mg/
ml) and 0.5% bupivacaine injected into the lesion for a period of 11 weeks has been shown to
be effective in a child patient. Relative contraindications do exist in certain medical conditions,
such as diabetes mellitus, peptic ulcer and generalized immunocompromised states. Calcito‐
nin nasal spray 200 U/spray once or twice daily was reported to be safe and effective for the
treatment of CGCG [40,46].
6. Conclusion
Literature reveals very few reported studies involving pediatric pathologies and there are
different treatment modalities for pediatric jaw tumors in the recent literatures. Many surgeons
find it difficult to decide which technique offers better results, and are also uncertain about
the factors which might influence their techniques of choice. The rapid growth and develop‐
ment process in childhood and adolescence affects the growth potential of tumors and tumor
like lesions and occasionally results in considerable morbidity. There are many rare odonto‐
genic tumors that may involve the head and neck in the pediatric population. Each of them
deserves careful attention by a multidisciplinary tumor board that includes pediatric oncolo‐
gists, radiation oncologists, dentists, and surgeons. Clinicians need to keep abreast of the
various intraosseous lesions with their presenting signs and symptoms, so that the patient can
be treated without any delay and avoiding unnecessary administration of antibiotics. Subse‐
quent to an unresponsive antibiotic therapy radiographs are taken to reveal a radiolucent or
radiodense lesion in the jaws. As a consequence the contribution of pathological examination
remains imperative in odontogenic cyst or tumor diagnosis. It is very important to consider
surgical and permanent dental concerns during jaw tumor treatment planning. Facial growth
and aesthetic results should be considered in the surgical planning.
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